Additionally, sufficient studies have suggested that SETD2, BAP1, mTOR, MUC16, HMCN1, KDM5C, ARID1A, and PTEN are intimately tied to prognosis and immune response in cancers (30–35). Here, SETD2 is linked to cancer.